HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
T-1249
Description
T-1249 is the first members of a new class of anti-HIV drugs which is also called fusion inhibitors. It has received fast track designation from the FDA and is in Phase I/II clinical testing.
No brand information found.
